Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Left ventricular systolic function following alcohol septal ablation for symptomatic hypertrophic cardiomyopathy.

Moss TJ, Krantz MJ, Zipse MM, Quaife RA, Sauer WH, Messenger JC, Groves BM, Salcedo EE, Schuller JL.

Am J Cardiol. 2014 Apr 15;113(8):1401-4. doi: 10.1016/j.amjcard.2014.01.417. Epub 2014 Jan 31.

PMID:
24576545
2.
3.

Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.

Almasood A, Garceau P, Woo A, Rakowski H, Schwartz L, Overgaard CB.

JACC Cardiovasc Interv. 2011 Sep;4(9):1030-4. doi: 10.1016/j.jcin.2011.06.008.

4.

Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.

van Ramshorst J, Mollema SA, Delgado V, van der Wall EE, Schalij MJ, Atsma DE, Bax JJ.

Am J Cardiol. 2009 Jun 1;103(11):1592-7. doi: 10.1016/j.amjcard.2009.01.373. Epub 2009 Apr 22.

PMID:
19463521
5.

Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography.

Sommer A, Poulsen SH, Mogensen J, Thuesen L, Egeblad H.

Eur J Echocardiogr. 2010 Dec;11(10):883-8. doi: 10.1093/ejechocard/jeq087. Epub 2010 Jul 28.

PMID:
20667848
6.

Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007.

Fernandes VL, Nielsen C, Nagueh SF, Herrin AE, Slifka C, Franklin J, Spencer WH 3rd.

JACC Cardiovasc Interv. 2008 Oct;1(5):561-70. doi: 10.1016/j.jcin.2008.07.005.

8.

[Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].

Wojtarowicz A, Kornacewicz-Jach Z, Kaźmierczak J, Szamlewski P, Gil R, Lewandowski M.

Pol Merkur Lekarski. 2002 Jul;13(73):25-8. Polish.

PMID:
12362500
9.

Effects of septal myectomy on left ventricular diastolic function and left atrial volume in patients with hypertrophic cardiomyopathy.

Tower-Rader A, Furiasse N, Puthumana JJ, Kruse J, Li Z, Andrei AC, Rigolin V, Bonow RO, McCarthy PM, Choudhury L.

Am J Cardiol. 2014 Nov 15;114(10):1568-72. doi: 10.1016/j.amjcard.2014.08.029. Epub 2014 Aug 27.

PMID:
25260948
10.
11.

Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM.

Eur Heart J. 2006 Aug;27(15):1805-10. Epub 2006 Jun 14.

PMID:
16774986
12.

Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.

J Am Coll Cardiol. 1998 Feb;31(2):252-8.

13.

Biventricular reverse remodeling after successful alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Chen YZ, Qiao SB, Hu FH, Yuan JS, Yang WX, Cui JG, Zhang Y, Zhou Y, Zhang CL.

Am J Cardiol. 2015 Feb 15;115(4):493-8. doi: 10.1016/j.amjcard.2014.11.030. Epub 2014 Nov 29.

PMID:
25541323
14.

Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.

Lu M, Du H, Gao Z, Song L, Cheng H, Zhang Y, Yin G, Chen X, Ling J, Jiang Y, Wang H, Li J, Huang J, He Z, Zhao S.

Circ Cardiovasc Interv. 2016 Mar;9(3):e002675. doi: 10.1161/CIRCINTERVENTIONS.115.002675.

15.

Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.

Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Spencer WH 3rd.

J Am Coll Cardiol. 1999 Oct;34(4):1123-8.

16.

Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.

Sitges M, Shiota T, Lever HM, Qin JX, Bauer F, Drinko JK, Agler DA, Martin MG, Greenberg NL, Smedira NG, Lytle BW, Tuzcu EM, Garcia MJ, Thomas JD.

Am J Cardiol. 2003 Apr 1;91(7):817-21.

PMID:
12667567
17.
18.

A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.

Shelke AB, Menon R, Kapadiya A, Yalagudri S, Saggu D, Nair S, Narasimhan C.

Indian Heart J. 2016 Sep - Oct;68(5):618-623. doi: 10.1016/j.ihj.2016.02.007. Epub 2016 Apr 14.

19.

Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.

Chang SM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF.

Circulation. 2004 Feb 24;109(7):824-7. Epub 2004 Feb 16.

Supplemental Content

Support Center